プロテアーゼ活性化受容体4
関連文献

“Protease-activated receptors in cardiovascular diseases.”. Circulation 114 (10):  1070–7. (2006). doi:10.1161/CIRCULATIONAHA.105.574830. PMID 16952995.
“Cloning and characterization of human protease-activated receptor 4.”. Proc. Natl. Acad. Sci. U.S.A. 95 (12):  6642–6. (1998). Bibcode: 1998PNAS...95.6642X. doi:10.1073/pnas.95.12.6642. PMC 22580. PMID 9618465. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC22580/.
“A dual thrombin receptor system for platelet activation.”. Nature 394 (6694):  690–4. (1998). Bibcode: 1998Natur.394..690K. doi:10.1038/29325. PMID 9716134.
“Gene and locus structure and chromosomal localization of the protease-activated receptor gene family.”. J. Biol. Chem. 273 (36):  23290–6. (1998). doi:10.1074/jbc.273.36.23290. PMID 9722561.
“Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.”. J. Clin. Invest. 103 (6):  879–87. (1999). doi:10.1172/JCI6042. PMC 408153. PMID 10079109. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC408153/.
“Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.”. Proc. Natl. Acad. Sci. U.S.A. 96 (20):  11189–93. (1999). Bibcode: 1999PNAS...9611189A. doi:10.1073/pnas.96.20.11189. PMC 18009. PMID 10500152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18009/.
“Cathepsin G activates protease-activated receptor-4 in human platelets.”. J. Biol. Chem. 275 (10):  6819–23. (2000). doi:10.1074/jbc.275.10.6819. PMID 10702240.
“PAR3 is a cofactor for PAR4 activation by thrombin.”. Nature 404 (6778):  609–13. (2000). Bibcode: 2000Natur.404..609N. doi:10.1038/35007085. PMID 10766244.
“Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.”. J. Immunol. 167 (11):  6615–22. (2002). doi:10.4049/jimmunol.167.11.6615. PMID 11714832.
“Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells.”. J. Immunol. 168 (7):  3577–85. (2002). doi:10.4049/jimmunol.168.7.3577. PMID 11907122.
“PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets.”. Arterioscler. Thromb. Vasc. Biol. 22 (5):  861–6. (2002). doi:10.1161/01.ATV.0000014742.56572.25. PMID 12006403.
“Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome.”. Thromb. Haemost. 87 (4):  722–7. (2003). doi:10.1055/s-0037-1613071. PMID 12008957.
“Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26):  16899–903. (2003). doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139241/.
Owen WG (2003). “PAR-3 is a low-affinity substrate, high affinity effector of thrombin.”. Biochem. Biophys. Res. Commun. 305 (1):  166–8. doi:10.1016/S0006-291X(03)00732-0. PMID 12732212.
“Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.”. J. Thromb. Haemost. 1 (4):  798–804. (2003). doi:10.1046/j.1538-7836.2003.00138.x. PMID 12871418.
“The role of PAR4 in thrombin-induced thromboxane production in human platelets.”. Thromb. Haemost. 90 (2):  299–308. (2004). doi:10.1160/TH03-02-0103. PMID 12888878.
“ZIP kinase triggers apoptosis from nuclear PML oncogenic domains.”. Mol. Cell. Biol. 23 (17):  6174–86. (2003). doi:10.1128/MCB.23.17.6174-6186.2003. PMC 180930. PMID 12917339. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC180930/.
“Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage.”. Biochem. J. 376 (Pt 3):  733–40. (2004). doi:10.1042/BJ20030954. PMC 1223816. PMID 13678420. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1223816/.
“Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium.”. J. Thromb. Haemost. 1 (10):  2206–15. (2004). doi:10.1046/j.1538-7836.2003.00436.x. PMID 14521606.